Skip to main content

Advertisement

You are viewing the new BMC article page. Let us know what you think. Return to old version

Maladie de La Peyronie | Open | Published:

Maladie de La Peyronie: La clinique a-t-elle encore un interet?

Clinical observation of La Peyronie’s disease

Resume

La simple observation clinique démontre:

  1. a)

    qu’une maladie de La Peyronie débutante est très différente d’une maladie de La Peyronie évoluée calcifiée,

  2. b)

    qu’une maladie de La Peyronie isolée ou associée à d’autres collagénopathies n’a probablement pas la même signification. Ainsi, la clinique conserve toujours une place essentielle dans la maladie de La Peyronie pour trois raisons majeures:

  1. 1.

    son diagnostic est avant tout clinique,

  2. 2.

    ses mécanismes étiologiques et physiopathologiques, son histoire naturelle restent encore mal connus d’où la nécessité de la recherche clinique,

  3. 3.

    l’évaluation plus objective de l’efficacité des nouveaux traitements médicaux exige une description précise de tous les paramètres cliniques.

Absract

The simple clinical observation shows that: a) a beginning La Peyronie’s disease is very different than an calficied and advanced one’s, b) physiopathologicaly, an isolated or associated to another collagenopathies La Peyronie’s disease has not likely the same signification, c) the efficiency of the medical treatment changes according to several clinical parameters (as node size, calcifications..). Thus, the clinic always keeps a major place in the La Peyronie’s disease for three main reasons: 1) its diagnosis is above all clinical, 2) its etiological and physiopathological mechanisms, its natural history still remain unclear, hence the need for the clinical research, 3) the more objective evaluation of the new medical treatment implies a precise description of all the clinical parameters.

Réferences

  1. 1.

    BARD RJ, AULD, RB, GAJEWSKI JB, GRANTMYRE JE, SMITH DC: Peyronie’s disease: a frequent cause of sexual complaints. Int. J. Impotence Res., 1992, 4 (suppl.2): P 165

  2. 2.

    BENSON GS: Peyronie’s disease. Editorial. J. Urol., 1993;149:1326.

  3. 3.

    BITTARD H, SCHRAUB S, BITTARD M: Traitement de la maladie de La Peyronie par association radiochirurgicale. Ann. Urol., 1988, 22:67–9.

  4. 4.

    BONDIL P, LOUIS JF, DAURES JP, COSTA P, LOPEZ C, NAVRATIL H: Clinical measurement of penile extensibility: preliminary results. Iint. J. Impotence Res., 1990,2: 193–201.

  5. 5.

    BONDIL P, SALTI AR, SABBAGH R, MASMOUDI S: The axial extensibility of the flaccid penis: comparative study between a group with La Peyronie’s disease (63 cases) and a control group (586 cases). Int. J. Impotence Res., 1995; 7 (suppl. I): 57.

  6. 6.

    BYSTROM J, JOHANSSON B, EDSMYR F, KORLOF B, NYLENS B: Induratio penis plastica (Peyronie’s disease). Scand. J. Urol. Nephrol., 1972, 6: 1–5.

  7. 7.

    BYSTROM J, RUBIO C: Induratio penis plastica (Peyronie’s disease): clinical features and etiology. Scand. J. Urol. Nephrol., 1976, 10:12–20

  8. 8.

    CARRIER S, LUE TF: For Peyronie’s disease, act conservatively. Contemporary Urology, 1994, 8:54–65.

  9. 9.

    CHESNEY J: Peyronie’s disease. Br. J. Urol., 1975, 47: 209–218.

  10. 10.

    CHILTON CP, CASTLE WM, WESTWOOD CA, PRYOR JP: Factors associated in the aetiology of Peyronie’s disease. Br. J. Urol., 1982, 54: 748–750.

  11. 11.

    DEVINE CJ Jr: Introduction. International conference on Peyronie’s disease. Advances in basic and clinical research. March 17–19 1993. J. Urol., 1997;157: 272–5.

  12. 12.

    DEVINE CJ, SOMMERS KD, JORDAN GH, SCHLOSSBERG SM: Proposal: trauma as the cause of the Peyronie’s lesion. J. Urol., 1997; 157: 285–90.

  13. 13.

    FURLOW WL, SWENSON HE, LEE RE: Peyronie’s disease: a study of its natural history and treatment with orthovoltage radiotherapy. J. Urol., 1975, 114: 69–71.

  14. 14.

    GALLIZIA F et GALLIZIA G: La maladie de La Peyronie et la disposition symétrique bilatérale des lésions collagènes concomittantes. J. Urol. Néphrol., 1972, 78: 116–127.

  15. 15.

    GASIOR BL, LEVINE FJ, HOWANNESIAN A, KRANE RJ, GOLDSTEIN I: Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie’s disease: a pharmacocavernosometric and pharmacocavernosographic study. World J. Urol., 1990, 8: 90–96.

  16. 16.

    GELBARD MK, DOREY F, JAMES K: The natural history of Peyronie’s disease. J. Urol., 1990, 144: 1376–9.

  17. 17.

    JOLIDON C, ZEPHIR D, YBERT G: Considérations historiques sur la maladie de LaPeyronie...peu de choses ont changé!. J. Urol., 1984, 90: 365–8.

  18. 18.

    LEPINARD V: Courbure de verge secondaire à une urétrotomie interne. Ann. Urol., 1983; 17: 380–1.

  19. 19.

    LEVINE AL, COOGAN CL: Penile vascular assessment using color duplex sonography in men with Peyronie’s disease. J. Urol., 1996; 155: 1270–3.

  20. 20.

    LINDSAY MB, SCHAIN DM, GRAMBSCH P, BENSON RC, BEARD CM, KURLAND LT: The incidence of Peyronie’s disease in Rochester Minessota, 1950 through 1984. J. Urol., 1991, 146:1007–9.

  21. 21.

    NOOTER RI, BOESCH JLHR, SCHOREDER FH: Peyronie’s disease and congenital penile curvature: long-term results of operative treatment with the plication procedure. Br. J. Urol., 1994, 74: 501–6.

  22. 22.

    PRYOR JP: Peyronie’s disease and impotence. Acta Urol. Belg., 1988;56:317–21.

  23. 23.

    RODRIGUEZ-VELA L, BERNE JM, CARELA J, GONZALVO A, GIL P, PAUL FJ, RIOJA LA: Peyronie’s disease: our experience. Int. J. Impotence Res., 1995 7 (suppl. 1): P61

  24. 24.

    SARRAMON JP, ESCOURROU G: The diagnosis and management of Peyronie’s disease. Int. J. Impotence Res., 1991, 3:69–83.

  25. 25.

    SMITH BH: Subclinical Peyronie’s disease. Am. J. Clin. Path., 1969, 52: 385.

  26. 26.

    SZOLLAR GP, PRANIKOFF K, KREMZER JE: Peyronie’s disease: an unusual localisation. J. Urol., 1984; 132:764–5.

  27. 27.

    VILJOEN IM, GOEDHALS L, DOMAN MJ: Reyronie’s disease: a perspective on the disease and the long term results of radiotherapy. S. Afr. Med. J., 1993;83:19–20.

  28. 28.

    VOSSHENRICH R, SCHROEDER-PRINTZEN I, WEIDNER W, FISCHER U, FUNKE M, RINGERT RH: Value of magnetic resonance imaging in patients with penile induration (Peyronie’s disease). J. Urol., 1995, 153: 1122–25.

  29. 29.

    WEIDNER W, ROMPEL R, WEISKE SCHROEDER-PRINTZEN I, RINGERT RH: Clinical features of Peyronie’s disease: a clinical study on 222 patients without previous treatment. Int. J. Impotence Res., 1992, 4, suppl. 2: A 116

  30. 30.

    WEIDNER W, SCHROEDER-PRINTZEN I, WEISKE WH, VOSSEHENRICH R: Analysis of 222 patients without previous local plaque therapy. J. Urol., 1997; 157:325–8.

  31. 31.

    WILLIAMS G, GREEN NA: The non-surgical treatment of Peyronie’s disease. Br. J. Urol., 1980, 52: 392–5.

Download references

Author information

Correspondence to P. Bondil.

Rights and permissions

Reprints and Permissions

About this article

Mots clés

  • La Peyronie
  • clinique
  • diagnostic
  • étiologie

key words

  • La Peyronie’s disease
  • clinic
  • diagnosis
  • etiology